News

Revolutionary cancer drug developed in Auckland set to begin clinical trials

Revolutionary cancer drug developed in Auckland set to begin clinical trials

A revolutionary cancer drug developed in Auckland is set to begin clinical trials.
Tarloxotinib is designed to help patients with head and neck cancers for which New Zealand ranks as one of the highest in the world for cases.
Auckland City Hospital radiation oncologist Dr. Andrew Macann joined Mike Hosking.

All the cancer you cannot see

All the cancer you cannot see

Lung cancer is the leading cause of cancer death in New Zealand with 1,700 deaths each year.
More New Zealanders die of lung cancer than of breast cancer, prostate cancer and melanoma combined.

Cracking the final piece of the human genome puzzle

Cracking the final piece of the human genome puzzle

Our own Professor Cris Print recently spoke to RNZ about how it’s taken thousands of scientists decades to finish mapping the human genome. The Detail looks at why it’s taken so long and what it might mean for indigenous populations here in Aotearoa and around the world.